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ABSTRACT
Background: Atrial ﬁbrillation (AF) is the most common arrhythmia affecting more than six million people in the
United States. The economic burden is estimated to be >$6 billion annually with catastrophic events dramatically
increasing expenditure. When patients experience symptoms, they commonly present to an acute care facility; this
can be costly and anxiety provoking.
Local problem: Same-day access issues prohibit patients from communicating directly with their cardiology provider, forcing them to use resources and increasing psychological burden.
Methods: A convenience sample, made up of 43 patients, was given a KardiaMobile device. Eligible patients had $2
AF-related emergency department (ED) or urgent care (UC) visits over 12 months, needed rate control with medication
titration, or were monitored for AF reoccurrence after reestablishing sinus rhythm.
Interventions: Patients emailed recordings daily and when experiencing symptoms. The recordings were reviewed
by a nurse practitioner (NP); abnormal readings were followed by a phone call, telehealth, or in-person visit.
Results: An independently designed survey was conducted online; almost all respondents (97%) found value in the
project and the device. Virtually all respondents (97%) felt that the program improved access. A majority (86%) reported
decreased anxiety. Had the respondents not been in the program, 34% indicated that they would have presented to an
ED and 25% would have presented to an UC, realizing a cost savings of $81,950 in reduced ED visits alone.
Conclusion: A personal electrocardiogram, with NP oversight, to manage AF is cost-effective and reduces unnecessary
resource utilization. It is patient centered, improves access, and empowers patients to manage their symptoms.
Keywords: Ambulatory ECG; atrial ﬁbrillation; cardiac arrhythmia; remote patient monitoring.
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Introduction
Atrial ﬁbrillation (AF) is the most common cardiac arrhythmia; it can result in ineffective atrial contraction and
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suboptimal ventricular ﬁlling, which can lead to hemodynamic compromise, and heart failure (HF). Consequences of AF and hemodynamic compromise vary from
person to person; AF can manifest as symptoms of
dyspnea, chest discomfort, palpitations, fatigue, hypotension, or syncope. Moreover, the psychological burden,
such as anxiety and helplessness, cannot be overlooked.
Finally, AF predisposes patients to cardiac thrombus
formation, placing them at a ﬁvefold increased risk for
stroke. Stroke and HF further increase the risk of morbidity and mortality related to AF (Morillo et al., 2017).
Problem and signiﬁcance
The current number of people in the United States with AF is
estimated to be between 2.7 and 6.1 million and predicted to
increase twofold by the year 2050 (Morillo et al., 2017). The
current economic burden, solely related to AF, is estimated
December 2021

· Volume 33 · Number 12

1307

Quality Improvement Report
to be more than $6 billion annually; as the number of patients double, it is reasonable to assume the economic
burden will concomitantly increase (Thompson et al., 2014).
In 2018, in a multispecialty group of a large health care
system, there were 43,054 patient visits associated with
various cardiac disease processes, of which 10,852 were
assigned a diagnosis code related to AF. A needs assessment was performed to evaluate same-day access to
cardiology providers; it was noted that patients would
present to an urgent care (UC) or an emergency department (ED) on the day they experienced symptoms
as a result of poor access. Many such cases, however, may
have been managed in the outpatient setting and would
not have required a visit to an acute care facility, as long
as rhythm and rate could be assessed and symptoms
managed virtually or from a distance (Anczykowski et al.,
2016).
Based on hospital claims data for this health care
system, the cost of hospitalizations related to AF from
June 2017 through May 2018 was in excess of $4 million.
During this same period, it was noted that 36 patients had
two or more hospitalizations; the average cost for these
admissions was estimated at $7,450 each.
History and development of innovative technology
Electrocardiography has evolved from the detection of
changing cardiac electrical potentials in 1887 by Ludwig and Waller. Einthoven, the “father of electrocardiography” developed recordings of the electrical
signals in 1901. Soon thereafter, the ﬁrst mobile cardiac monitoring unit was developed by Norman Holter
in 1947, which led to the event monitor, providing the
ability to extend monitoring up to 30 days (Garabelli
et al., 2017). Real-time telemetry was the next evolution
followed by implantable loop recorders and, most
recently, smartphone technology. Improvements in
technology have increased the utilization of mobile
devices to deliver care at a distance; it has also shown
to be an effective intervention to decrease anxiety and
unnecessary hospitalizations and visits to EDs and UCs
(Demeester et al., 2018). Successful applications
thereof to cardiac conditions in general—and AF in
particular—have improved care, reduced symptomatology, and improved the quality of life. The purpose
of this nurse practitioner (NP)–led quality improvement project was to improve patient outcomes, decrease resource utilization, and reduce anxiety related
to AF through the use of a personal, single-lead electrocardiogram (ECG).

Methods
An NP belonging to a cardiology division of a large,
multispecialty group, which is a subsidiary of a national health care organization, conducted a quality
1308
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improvement project to evaluate the impact of providing patients with a personal single-lead ECG and
telehealth access. Outcomes of AF-related resource
utilization, the patient’s level of anxiety, and patient
satisfaction with care and access were evaluated.
Population
Eligibility criteria included adult patients who (1) had two
or more AF-related ED or UC visits in the past 12 months,
(2) needed rate control with medication titration, or (3)
needed monitoring for AF reoccurrence after reestablishing sinus rhythm—either by chemical or direct current
cardioversion. Additionally, participants needed to be
established with the clinic, able to understand and consent to participation, and have comfort using the personal ECG device and application on their smartphone.
Forty-three patients were identiﬁed and participated in
the project.
Intervention
Patients who participated received a KardiaMobile (KM)
device, provided by the practice. The AliveCor KM device
consists of two electrodes with the ability to record a 30second Lead I rhythm strip. The ECG recording can be
viewed in real time through the smartphone application.
The recording was then emailed to an NP for review and
potential management. The patient is able to view an
instant analysis of their cardiac rhythm alerting them to
“potential atrial ﬁbrillation,” “bradycardia,” “tachycardia,”
or “normal sinus rhythm.” Other arrhythmias that may be
considered “unclassiﬁed” by the device algorithm were
interpreted by an NP.
The KM device ﬁrst received FDA 510k clearance in 2012
and was available by prescription only in 2013. The device
became available to patients for over-the-counter purchase in 2014 (Garabelli et al., 2017); in 2019, the device cost
averaged $99. Numerous studies, with varying comparisons and outcomes, have validated and supported the use
of the KM device (Bumgarner et al., 2018; Halcox et al., 2017).
To further improve access, a telehealth platform, NowClinic, was also implemented to provide an alternate
method of communication; patients are then able to log in
whenever and wherever for a face-to-face visit.
Protocol and data collection
Following institutional review board approval, informed
consent was obtained; patients were provided with a KM
device and assisted with downloading the Kardia and
NowClinic applications on their smartphone. Enrollment
and distribution of the KM devices occurred over several
weeks. This time frame included ample time to assist with
the use of the KM device and emailing ECG recordings to
the dedicated email address at the practice. A baseline
rhythm recording was obtained and emailed, during the
enrollment visit. Patients were followed for eight weeks
www.jaanp.com
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and instructed to record and email an ECG at least once
daily as well as when symptomatic. Symptoms were deﬁned as, but not limited to, chest discomfort, shortness of
breath, palpitations, lightheadedness, and dizziness.
An NP would review the ECGs daily. Patients were
aware that ECGs would be read Monday through Friday
between the hours of 8:00 a.m. and 5:00 p.m.; patients
were advised to proceed to an UC or ED if symptomatic
outside of those hours. If the recordings were normal,
daily transmissions continued. If abnormal, attempts
were made to contact the patient within an hour of ECG
review, by telephone or email; once contact was made,
the patient was offered a NowClinic visit, although most
were comfortable with telephone follow-up. Figure 1
shows the project ﬂow and protocol.
All demographic information and patient characteristics were obtained from the respective patients’ medical
records and recorded at the time of enrollment. ECG recordings were reviewed and then forwarded to medical
records to be scanned into the patient’s chart.
Participants completed two online surveys. One survey, administered by the organization’s patient experience team, assessed satisfaction with access to care,
reduction in ED visits, and a reduction in the level of
anxiety. A link to this survey was emailed anonymously to
all participants at the end of the 8-week period. The organizational satisfaction survey is made up of nine

questions. These questions address how the patient
perceives access and communication with a cardiology
provider, if unnecessary hospitalizations were avoided,
and if anxiety levels were decreased. In addition, the
survey queried disposition—where the patient stated that
they would have sought care—were the program not
available. Options for disposition on the survey include
an ED, UC, ofﬁce visit, or done nothing.
A second tool, the Hospital Anxiety and Depression
Scale (HADS), is a cost-effective, validated tool that has
been used in both the hospital and community settings
(Stern, 2014). This self-rating, screening scale is composed of 14 questions (7 assessing anxiety and 7
assessing depression), takes approximately 2–5 minutes
to complete and facilitates early detection of anxiety
and depression (Snaith, 2003). Score calculation and
results interpretation indicate the severity of the mood
disorder. A link was emailed to each patient within the
ﬁrst week and then again at the end of the 8-week period
to determine if there was a change in pre- and postanxiety levels. For this quality-improvement project, the
level of anxiety as it relates to the diagnosis of AF was
evaluated.

Results
Table 1 displays the patient characteristics; of the 43 patients
enrolled, 53% were men (n = 23); the mean calculated age was

Figure 1. The project ﬂow and protocol.
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patients’ recordings made up 44% of the unclassiﬁed
rhythm strips.
One other patient, whose recordings demonstrated
short bursts of supraventricular tachycardia, had a total
of 13 instant rhythm assessments categorized as unclassiﬁed. The remaining 84 recordings were made up of a
combination of sinus rhythm with premature atrial contractions (34), sinus rhythm with a signiﬁcant number of
premature ventricular contractions (30), or too much artifact to be interpreted (20).
Of the 43 patients, 17 required medication titrations for
rate control, symptom control, or both. Of interest 3 of the
17 patients were thought to have been rate controlled.
These patients were asymptomatic and experiencing high
ventricular rates (HVRs), deﬁned as $115 beats per minute. Of the three, one patient lived in a neighboring
county, 63 miles from the clinic. Management of that
patient’s care was accomplished by coupling the use of
the KM device with telehealth; communication resulted in
several adjustments to medications and prompted a referral to an electrophysiologist for consideration of ablation. The other two patients were able to be rate
controlled and converted back to sinus rhythm. During
the monitoring period, two patients had cardiac ablation
and subsequently remained in sinus rhythm.

Table 1. Patient Characteristics
No. of Patients

N = 43

Age, years, mean 6 SD

66.79 6 9.78

Gender, male, n (%)

23 (53)

Ethnicity, n (%)
Caucasian

31 (77)

African American

4 (10)

Hispanic

3 (8)

Asian

2 (5)

66.79 6 9.78 years (median = 69.00 years; range = 35 years). The
cohort ethnicity was made up of 77% Caucasian, 10% African
American, 8% Hispanic, and 5% Asian. Moreover, 84% of the
patient population resided in the city where the practice is
located, 11% in the surrounding area, and 5% in a neighboring
county, approximately 63 miles west of the city.
Cardiac rhythm
A total of 1,501 ECG recordings were received and
reviewed by the end of eight weeks. Results of the KM
device instant rhythm analysis revealed that 710 recordings were interpreted as normal sinus rhythm and 537
were interpreted as possible AF; of these, 74 had rapid
ventricular rates. There were 173 unclassiﬁed interpretations, 46 bradycardic, 24 tachycardic, 8 deemed uncategorized (due to artifact), and 3 recordings were too short
to be interpreted.
Unclassiﬁed readings occur when the rhythm cannot
be categorized as normal, possible AF, bradycardia, or
tachycardia. Of those designated as “unclassiﬁed,” the
majority came from two patients. The ﬁrst patient’s
baseline rhythm was sinus arrhythmia; the other patient’s
baseline rhythm was sinus with a ﬁrst-degree atrioventricular block and left bundle branch block. These two

Patient surveys
The patient experience and satisfaction surveys were
completed by 33 patients (response rate of 77%). The
majority of patients gave top ratings for the program’s
ability to decrease anxiety level (62% rated 5), provide
empowerment to manage health concerns (72% rated 5),
and increase ability to communicate with a provider and
health care team (84% rated 5), as shown in Table 2. Ratings were on a Likert-scale, with “1” representing that the
program did not meet the question objective and “5”
representing that the program did meet the question
objective.

Table 2. Patient Experience and Satisfaction Survey: Rating results
Question, n (%)

1—Did Not

2

3

4

5—Did

Mean Rating

Has the program decreased your
anxiety level?

1 (3)

1 (3)

2 (6)

7 (24)

18 (62)

4.4

Has the program empowered you to
manage your overall health concerns?

0 (0)

0 (0)

4 (12)

5 (15)

24 (72)

4.6

Has the program increased your ability
to communicate with your provider and
health care team?

0 (0)

0 (0)

0 (0)

5 (15)

28 (84)

4.8

How likely are you to recommend this
device to other patients with atrial
ﬁbrillation?

0 (0)

0 (0)

1 (3)

1 (3)

30 (90)

4.8
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Table 3. Patient Experience and Satisfaction
Survey: Binary results
Question, n (%)

Yes

No

Did you ﬁnd value in the mobile pilot’s
additional service as well as the
device?

32 (97)

1 (3)

Has the program improved your ability
to directly access your provider?

32 (97)

1 (3)

Has the program reduced unnecessary
emergency department visits?

29 (87)

4 (12)

depression. Because of the small number of respondents
with both a baseline and follow-up survey results, statistical comparison of the pre- and post-results was not
conducted.

Discussion

When considering the ratings as scores, the overall
average was 4.4 for the ability of the program to decrease
anxiety level, 4.6 for being empowered to manage health
concerns, and 4.8 for increased ability to communicate
with a provider and health care team. Respondents were
highly satisﬁed with 90% of them giving a rating of 5 when
asked how likely they were to recommend the KM device
to other patients diagnosed with AF. The survey also
asked three yes/no questions (Table 3). Almost all respondents (97%) found value in the additional services
and the device. Virtually, all respondents (97%) also felt
that the program improved their ability to directly access
their provider, and the majority of the respondents (87%)
also felt that the program reduced unnecessary ED visits.
In addition to the yes/no question regarding unnecessary ED visits, the questionnaire asked what respondents would have done if the program were not
available to them; this question provided more detailed
insight into patient-reported reductions in utilization.
Had the respondents not been in the program, 34% (n = 11)
reported that they would have presented to an ED, and
25% (n = 8) would have presented to an UC facility; this is
shown in Figure 2.
A total of 86 HADS surveys were administered; there
were 30 preintervention surveys returned, and 21 postintervention. The HADS scoring identiﬁes patients who
are likely to have clinical anxiety or depression. Of the 30
preintervention surveys, 18 patients did not have anxiety;
nine patients had borderline anxiety, and three patients
were rated as having abnormal anxiety-related to AF. Of
the 21 postintervention surveys completed, 15 did not
have anxiety, 2 were borderline, and 4 were found to have
anxiety.
Although depression was not a prespeciﬁed outcome
of this project, depression results from the HADS are
presented. Three patients were found to be depressed,
two had borderline depression, and 25 did not have any
reported depression. The post-survey rated two patients
with depression, both of whom were receiving treatment
from their primary care provider; two patients were rated
with borderline depression, and 17 patients without
Journal of the American Association of Nurse Practitioners

In the current environment, telehealth and remote patient monitoring (RPM) is more important than ever.
Medication management can be difﬁcult to perform remotely and often results in the patient seeking care in an
UC or ED. Not only is this costly to the health care system
but also causes anxiety in patients and their caregivers,
which is a symptom that is often neglected.
Technological advances have increased providers’
ability to better manage their patients, especially when
access to care has proven more challenging. The KM
device, monitored by an NP, is a convenient and costeffective example of such technology that enables
more proactive and higher-quality patient care. Patients’ data can be measured at any time, and from
anywhere, with the use of a smartphone; moreover, the
component of the provider’s immediate intervention
plays a critical role. More proactive and immediate
feedback to patients when they were experiencing
abnormal rhythms not only avoided costly resource
utilization, but also reduced psychological burden for
the patient. Patients also felt empowered to manage
their AF and less anxious about their condition.
Some patients experienced multiple episodes of abnormal rhythms. The actual number of avoided resource
utilization is higher than the patient responses to the
survey; however, if considering 11 patients who avoided
an ED visit, this quality-improvement project realized a
cost savings of $81,950, using the previously calculated
average for an ED visit. This is signiﬁcantly underestimated because potential hospitalizations and diverted UC visits are not included. Remote monitoring also
has the potential to extend its reach to rural and underserved areas. This distance monitoring was demonstrated by those patients who sent recordings from the
neighboring city more than 60 miles away, while on a

Figure 2. Resource utilization by patient self-report.
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cruise ship vacation, and from other countries such as
Mexico.
Of interest, patients who were thought to be rate
controlled were identiﬁed as experiencing HVRs. The
signiﬁcance of rate control translates to hemodynamic
stability and prevention of tachycardia-induced cardiomyopathy, which may further result in HF. Cardiac decompensation, in the absence of rate control, can result
in symptoms experienced by the patient and further drive
health care expenditure. Notwithstanding the advantages
of the technology used, the value of the expert clinician
is a critical component of this type of care delivery.
Limitations
The project involved a single, cardiology practice and may
not be representative of patients in other practices or
geographic locations. Statistical testing could not be
conducted given the small number of participants. The
KM device has the potential for long-term monitoring;
thus, a project with longer follow-up would be needed to
examine the use of KM beyond eight weeks. Furthermore,
4 of the 43 participants had already been using their own
KM device prior to enrollment; therefore, they may have
already experienced a reduction in anxiety levels through
their use and comfort with the device prior to the project
period. Utilization reductions were based on patient selfreport and did include clinical review of the episodes to
document the clinical pathway of the patient; moreover,
patient recall could be an issue with completion of the
survey at the end of the project period. Finally, there are
many uses of the KM device that were not included, such
as screening high-risk patients for AF, investigation of
symptomatic patients (e.g., palpitations) for AF, and the
like. Future projects should explore more of the potential
uses for KM.
The KM device also has some limitations. The KM algorithm interpreted three recordings as possible AF.
Upon review, the recordings were noted as sinus rhythm
with frequent premature atrial contractions. As previously mentioned, there are many arrhythmias, such as
sinus arrhythmia or bundle branch blocks, that are
interpreted by the device as “unclassiﬁed.” The ability
for an NP to review ECGs, interpreted as “unclassiﬁed,” is
critical to proactive patient care and identifying potentially high-risk arrhythmias. Patients with atrial ﬂutter
and regular R-to-R intervals were also interpreted as
normal. Furthermore, those with permanent pacemakers
are not able to use the device because it creates interference or noise, which results in an unreadable
interpretation.
Patients with movement disorders, such as Parkinson’s disease, may not be able to produce a quality recording because patients must remain stationary for a
period of 30 seconds. The KM device does not have the
capability for continuous monitoring beyond a brief time
1312
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frame; therefore, patients who require observation
around-the-clock would necessitate a traditional Holter
or a continuous event monitor.
Potential for sustainability
Learnings from this quality-improvement project were
helpful in understanding the long-term sustainability of
using the KM device more widely in our practice. The need
for near real-time review of patients’ ECG recordings
would require additional personnel, cardiovascular
technicians, who could assist in reviewing ECGs. Additionally, it is helpful to integrate the ECG recordings directly into the patients’ medical record. Integration of the
KM device recordings with our practice’s cardioserver will
eliminate the delay of transferring an ECG into a patient’s
chart; once a provider conﬁrms the interpretation, it will
be available for immediate review in the electronic
medical record.
The project also illustrated that use of the KM device is
cost effective for our practice. The use of KM for this
project falls under RPM and is reimbursed under the
Current Procedural Terminology codes: 99457 for RPM
with a minimum of 20 minutes of treatment and management per month and are billable by an NP. Additional
codes, such as 99453 for RPM set up and education, are
also applicable. With these RPM codes and the savings
from reduced utilization, the KM device is a cost-effective
option for our practice, even when including the cost of
additional support staff. Moreover, the organization’s
cardiology Holter and event monitor access would signiﬁcantly improve because many patients do not require
around-the-clock monitoring. The wait time for availability of these devices could be substantially reduced
with the use of KM. Thus, the project has conﬁrmed the
overall beneﬁts of implementing the use of KM.
Suggestions for further research
As discussed previously, replicating this project across
multiple sites with a larger sample size and the inclusion
of all potential use cases would be beneﬁcial in
addressing limitations. Asymptomatic AF has become
increasingly common in the aging population and may
not present until the patient experiences a devastating
event. Patients aged 65 years or older may beneﬁt, with
the use of the KM device and clinician oversight, by submitting recordings for routine screening, which would
allow for early detection of AF, which may in turn curtail
potential catastrophic events, further decreasing health
care expenditure. Additionally, and more particularly related to this project, further research using the KM device,
with a larger cohort and for an extended period of time, is
warranted to evaluate anxiety related to AF, patient satisfaction with access to care, and the overall reduction of
resource utilization.
www.jaanp.com

T. Praus et al.

Conclusion
This quality-improvement project provides evidence that
implementing the use of a personal, single-lead ECG to
manage AF patients is cost effective and improves patient
outcomes while reducing unnecessary resource utilization. It is also patient centered as patients become more
empowered in the management of their AF, whereas
anxiety, related to their AF is reduced. Most importantly,
patients feel they have better access to their cardiology
providers, and patients living in isolated areas, or traveling to other cities and countries, can be managed
remotely.
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